R&D Platform

Consun has spared no effort in investment in the R&D sector, always focusing on medical and pharmaceutical technological innovation and the in-depth integration of industry, academia, and research.
Up to now, Consun has established a "Kidney Disease Drug Research Center" invested by the enterprise, with an R&D team of over 100 people. Meanwhile, it owns 1 "Postdoctoral Research Station", 1 provincial-level "Engineering Technology Research Center", 1 provincial-level "Technology Innovation Center", 1 provincial-level "Enterprise R&D Center", and 2 provincial-level "Enterprise Technology Centers".